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Background: Ticks are the most important vectors of disease-causing pathogens in domestic animals and are
considered to be second worldwide to mosquitoes as vectors of human diseases. In Europe, Ixodes ricinus, the
sheep tick, plays an important role as companion animal parasite but is also the primary vector of medically important
diseases such as tick-borne encephalitis and Lyme borreliosis.
The present study was designed to evaluate the efficacy under laboratory conditions of a new fixed spot-on combination
of fipronil and permethrin (Effitix®, Virbac) in treating and preventing tick infestations of Ixodes ricinus in dogs.
Methods: Twelve dogs were included in this randomized, controlled, blinded laboratory study. They were randomly
allocated to two groups of six dogs each according to their pre-treatment live attached Ixodes ricinus tick count. On day
0, the dogs from Group 2 were treated with the recommended dose of Effitix®, the dogs from Group 1 remained untreated.
On days −2, 7, 14, 21, 28 and 35, all dogs were infested with 50 (±4) viable unfed adult Ixodes ricinus (20 ± 2 males,
30 ± 2 females). Ticks were removed and counted at 48 ± 2 hours post product administration or tick infestations.
Results: Through the study, the tick attachment rates for the untreated group were greater than 25% demonstrating
that adequate levels of infestation were reached on the control dogs. Based on both arithmetic and geometric means
(AM and GM), Effitix® was deemed to be effective against Ixodes ricinus on days 2, 9, 16, 23, 30 and 37 with a percentage
of efficacy of 98%, 100%, 100%, 100%, 93% and 95% respectively (AM). No clinical abnormalities were detected during
the study.
Conclusions: The study has shown under laboratory conditions, that Effitix® is a safe and an effective combination to treat
and protect dogs from Ixodes ricinus up to 37 days after administration. The high immediate efficacy of 98% evaluated
at 48 hours post-treatment was particularly interesting, meaning that Effitix has a curative effect against ticks (Ixodes ricinus)
and provides a rapid control of existing Ixodes ricinus infestation on a dog at the time of treatment.
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Ticks are among the most common and important ecto-
parasites on dogs worldwide [1]. Tick bites can directly
harm the animal by causing mechanical irritation and in-
flammation of the skin but more importantly through
transmission of a large range of pathogens including vi-
ruses, bacteria, protozoa and helminths that may cause
severe diseases both in humans and animals. Ticks are* Correspondence: christelle.navarro@virbac.com
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causing pathogens in domestic and wild animals and
second worldwide to mosquitoes as vectors of human
diseases [1].
In Europe, Ixodes ricinus (Acari: Ixodidae) known as the
sheep tick or the castor bean tick, is the primary vector of
medically important disease agents like the tick-borne en-
cephalitis complex of viruses, the Borrelia burgdorferi
sensu lato complex, the causative agents of Lyme borrelio-
sis, Rickettsia, Babesia, and Anaplasma species [2]. I. rici-
nus is by far the most common tick species recently
identified in many countries and/or European regionsal. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0) which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Categorization of ticks for counting (adapted
from EMEA/CVMP/EWP/005/2000-Rev.2, 2007)
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Spain, Italy, the Balkans, and eastern Europe [3].
As an ectotherm that spends the majority of its life
cycle free-living, I. ricinus is sensitive to climatic condi-
tions requiring a high relative humidity (at least 80%) to
survive during its off-host periods and is usually found
in areas of moderate to high rainfall with vegetation that
retains high humidity [3]. Typical habitats of I. ricinus
include deciduous and coniferous woodland, heathland,
moorland, rough pasture, forest and urban parks [3].
However, a recent expansion in the geographic distribu-
tion of I. ricinus has been described to higher latitudes
and altitudes together with an increase of its abundance
in Europe. The driving forces for these changes have not
been totally identified but a change in climate may play an
important role in certain geographic regions. In addition,
other ecological changes such as how we manage habitats,
the distribution and abundance of tick hosts and/or the
increasing initiatives to create natural environments and
the trend towards spending more time in nature for recre-
ational activities are also important considerations, leading
to an increased risk of disease caused by these pathogens,
in particular of Lyme borreliosis [3-5].
It is now accepted within the scientific community
and the public health authorities that veterinarians, phy-
sicians and pet owners must take measures to protect
companion animals from possible ectoparasitic infesta-
tions. This protection is required not only to relieve pets
from the mechanical irritation and inflammation caused
by the ectoparasites but also to protect them from the
potential vector-borne diseases they may carry and more
importantly, to limit the risks associated with zoonotic
transmission of diseases. Ectoparasite management in dogs
is therefore fundamental and a perfect example of the ‘One
health’ approach which aims at fostering an environment
which supports healthy animals and healthy people [6-8].
Effitix® is a combination of two active ingredients:
fipronil and permethrin. The use of these two active
product ingredients as pesticides is well-established in
agriculture, the domestic environment and veterinary
medicine. Fipronil belongs to the phenylpyrazole family
and has acaricidal and insecticidal properties. Fipronil’s
putative mode of insecticidal action is interference with the
passage of chloride ions through the gamma- aminobutyric
acid (GABA)-regulated chloride ion channel, which results
in uncontrolled central nervous system activity and sub-
sequent death of the insect [9]. Permethrin belongs to
the family of synthetic chemicals called pyrethroids and
has well-known strong repellent effects, in particular
against diptera, that are sufficient to disorientate and ir-
ritate them resulting in the absence or reduction of
blood feeding (anti-feeding effect) [10]. Permethrin can
also act as an acaricide and insecticide, with repellent ef-
ficacy. The spectrum of activity of permethrin includesflies, mosquitoes, fleas, ticks, lice and mites. Permethrin
binds to Na+ channels causing a slowing of their rate of
closure resulting in repetitive firing/stimulation of
nerves, depolarisation and nerve block. The type I pyre-
throids produce a distinct poisoning syndrome charac-
terised by progressive fine whole body tremors, exaggerated
startle response, uncoordinated muscle twitching and hy-
perexcitability, resulting in death of the parasite. The effects
are generated largely by their action on the central nervous
system.
The objectives of the study performed were to test the
acaricidal effect of the combination against ticks (I. ricinus)
in dogs.Methods
Study design
This was a randomized, controlled, blinded laboratory
study. The design followed the recommendations of the
European guidelines for the testing and evaluation of the
efficacy of antiparasitic substances for the treatment and
prevention of tick and flea infestation in dogs and cats
[11] and the latest World Association for the Advance-
ment of Veterinary Parasitology guidelines to conduct
laboratory studies to assess the efficacy of ectoparasiti-
cides applied to dogs and cats [12]. Eighteen dogs (male
and female) were acclimatised for the study. During the
acclimatisation period, animals were assessed to deter-
mine their ability to retain ticks post-infestation. Twelve
dogs that met the inclusion criteria were then included
in the study and randomized according to their pre-
inclusion tick count into two groups of six dogs each.
Animals assigned to Group 2 were administered Effi-
tix®, on day 0. Animals in both groups were infested with
50 (±4) viable unfed adult I. ricinus (20 ± 2 males, 30 ± 2
females) on days −7 (7 days prior to administration of
Effitix®), −2, 7, 14, 21, 28 and 35. On days −5 (5 days
prior to administration of Effitix®), 2, 9, 16, 23, 30 and 37
(approximately 48 ± 2 h post-infestation, except for day
2 which was approximately 48 ± 2 h after the application
of Effitix®), all ticks were counted and removed and cate-
gorized as described in Table 1. Efficacy was defined by
the group mean live and dead engorged ticks in Group 2
when compared to the mean live tick count in the
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treatment. On day 2, dead engorged attached ticks were
not included in the analysis. An effective dose was ex-
pected to provide more than 90% reduction in tick
counts compared to the control group when using arith-
metic means (AM).
This study was carried out according to Good Clinical
Practice [13]. The protocol was approved by the ethics
committee of Charles River Laboratories Preclinical Ser-
vices Ireland Ltd (reference F004\12-002).
Selection of the dogs
Twelve healthy Beagle dogs, 5 male and 7 female, weigh-
ing 8.2 to 14.0 kg and identified by electronic transponders
with unique alphanumeric codes were selected for inclu-
sion in the study. Dogs were individually housed to pre-
vent cross contamination. On day −7, approximately 50
(±4) viable unfed adult I. ricinus of mixed sex ratio (20 ± 2
males, 30 ± 2 females) were applied to clinically healthy
adult dogs. On day −5 (48 ± 2 h post-infestation), the
number of live attached ticks were counted and recorded
and all ticks were removed. To be included in the study, at
least 25% of the ticks placed on the dog on day −7 (and
counted on day −5) had to be recovered as live attached.
Treatment
Dogs in group 1 remained untreated whereas dogs in
group 2 received one pipette of Effitix® [the combination
(fipronil 6.1% w/vol and permethrin 54.5% w/vol)] once
on day 0. Dogs were weighed on day-7 for randomization
purpose and on days −1 for treatment dose adjustment.
Dogs weighing between 4.1 and 10 kg received one
1.1 mL pipette and dogs weighing between 10.1 and 20 kg
received one 2.2 mL pipette. The product was applied top-
ically as a spot-on, in approximately equal volumes at two
application sites: one application between the shoulder
blades and the second application at the lumbar area.
After parting the hair, the product was applied directly to
the skin. In order to maintain blinding of the study, the
animals were treated by an individual who was not in-
volved in post-treatment assessments and observations.
Dogs were observed throughout the study for any clinical
abnormalities.
Tick infestations
Dogs were infested with I. ricinus of European origin
(Germany, Bratislava, Ireland) and genetically enriched
each year with new genetic seed stock from European
countries. At each infestation time point, days −2, 7, 14,
21, 28 and 35, approximately 50 viable unfed adult I.
ricinus (20 ± 2 males, 30 ± 2 females) were applied to
each dog. Each dog was infested with ticks in its housing
location. The ticks were applied gently to the mid-
thoracic region and allowed to crawl into the hair coatand select an attachment site. Tick infestation was per-
formed on sedated dogs. The dogs were sedated using
xylazine (20 mg/mL) (Xylapan®, Vetoquinol, Buckingham,
UK or Chanazine®, Chanelle, Berkshire, IE) and ketamine
(100 mg/mL) (Vetalar®, Zoetis, London, UK or Narketan
10®, Vetoquinol, Buckingham, UK) at a rate of 0.1 mL/kg
each.
Tick counts
On days 2, 9, 16, 23, 30 and 37, 48 h (±2 h) post-dosing
or post-infestation, the ticks were counted and removed.
The examiner(s) systematically examined the head, all
dorsal and ventral areas and the legs of the dog. At each
tick count and collection, the numbers of female live or
killed attached ticks, and female live and/or killed free
ticks were quantified and all ticks were removed from
the dog. Following removal, live attached ticks and killed
attached ticks from each dog were categorized on the
same day as described in Table 1. The engorgement sta-
tus was then determined for each tick by squashing to
ensure that digested blood was present.
Efficacy assessment
Tick attachment rates
For tick counts, at each time point, the number of “at-
tached live” ticks and the “attached live” tick rates were
calculated and reported for Group 1 (untreated control)
to confirm the vigor of the ticks. Twenty five to fifty per-
cent of these ticks should attach to the animal at each
time point following infestation in the control group. As
30 ± 2 female ticks were applied (I. ricinus males do not
attach to their hosts), calculations were based on 30
ticks only.
Acaricidal efficacy
The AM and geometric mean (GM) tick counts were
calculated for each group on each evaluation day. The
percentages of efficacy against ticks were calculated as
follows:
Efficacy %ð Þ against ticks ¼ 100 x Mc – Mtð Þ = Mc;
where:
Mc = AM or GM number of live ticks on dogs in the
negative control group at a specific time point,
Mt = AM or GM number of live ticks and dead
engorged ticks on dogs in the treated group at a specific
time point.
Note: on day 2, dead engorged attached ticks were not
included in the analysis as the product was applied 48 h
after infestation and female ticks had time to start blood
feeding [12].
Table 2 Mean number of live attached ticks and attachment rate (%) in the untreated control group by study day
Day 2 Day 9 Day 16 Day 23 Day 30 Day 37
Mean 21.3 (71%) 17.0 (57%) 16.5 (55%) 19.7 (66%) 20.8 (69%) 20.7 (69%)
Minimum 17 (57%) 13 (43%) 12 (40%) 16 (53%) 15 (50%) 19 (63%)
Maximum 26 (87%) 21 (70%) 22 (73%) 25 (83%) 25 (83%) 23 (77%)
SD 3.1 (10%) 3.7 (12%) 3.8 (13%) 3.1 (10%) 3.8 (13%) 1.6 (5%)
Mean: Arithmetic mean, SD: standard deviation.
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The groups were compared using one-way ANOVA with a
treatment effect for days 2 and 30. For days 9, 16, 23 and
37, the comparisons were made using the Kruskal-Wallis
test. The counts on these study days were not suitable for
analysis using ANOVA due to violations of one or both of
the normality or equal variance assumptions. The statistical
unit was the individual animal. All analyses were per-
formed using programs in SAS® (Version 9.2). All statistical
tests were two-tailed with a level of significance of 5%.Results
All animals used in the study met the inclusion criteria
and were not prohibited from inclusion by the exclusion
criteria. Groups were homogeneous at baseline according
to sex, age and weight (p > 0.05). All animals assigned to
group 2 were successfully treated with Effitix®; all infesta-
tions, tick counts, clinical assessments and bodyweight re-
cordings were performed at the required time-points. No
clinical abnormalities were observed in any dogs during
the study and no concomitant treatment had to be
administered.Tick attachment rates
The results (Table 2) show that the experimental infesta-
tions with I. ricinus were successful, with retention rates on
the control untreated dogs ranging between 55% (day 16)
and 71% (day 2) providing a severe challenge to assess the
acaricidal effect of the combination product.Table 3 Arithmetic mean and geometric mean of Ixodes ricinu
(Day 2) or 48 h after each re-infestation (Days 9, 16, 23, 30, 3
Day Group 1: negative control
Arithmetic mean Standard deviation Geometric mean
+2 21.3 3.1 21.1
+9 17.5 3.4 17.2
+16 16.5 3.8 16.2
+23 19.7 3.1 19.5
+30 20.8 3.8 20.5
+37 21.2 2.1 21.1
1: Group 2 differed statistically significantly (p < 0.05) from the untreated control GrEfficacy
The AM and GM number of ticks that were present on
untreated control dogs and on treated animals at 48 h
after treatment or after each infestation are shown in
Table 3. The calculated percent efficacy (GM and AM)
for each time point are given in Table 4.
For both AM and GM, immediate efficacy, based on tick
reduction was equal to 98% on study day 2 demonstrating
that the combination had an excellent immediate curative
effect. Efficacy was still > 90% for both AM and GM on
days 9, 16, 23, 30 and 37 showing thus that the product
had residual tick efficacy for a further 35 days.
Tolerance
No clinical abnormalities were detected during the
study. Only classic transitory cosmetic effects of a spot-
on application like greasy appearance and/or clumping
and/or spiking of the coat were observed during 24 h at
both sites of administration.
Discussion
In this study, a single treatment with the combination
achieved more than 98% therapeutic efficacy for treating
pre-existing infestation by I. ricinus. It was followed by a
five weeks post-treatment residual efficacy as demon-
strated by the prophylactic efficacy.
Acaricidal effect
The acaricidal efficacy observed in this study against I.
ricinus is similar to what is usually observed in equivalents(attached and not attached) counts 48 h after treatment
7)
Group 2: treated (Effitix®)
Arithmetic mean Standard deviation Geometric mean
0.5 (1) 0.8 0.4
0.0 (1) 0.0 0.0
0.0 (1) 0.0 0.0
0.0 (1) 0.0 0.0
1.5 (1) 2.8 0.7
1.0 (1) 0.9 0.8
oup 1 on all assessment days.
Table 4 Percentage efficacy of Effitix® against Ixodes
ricinus 48h after treatment/infestation (geometric and
arithmetic mean)
Means Days of treatment
21 92 162 232 302 372
Arithmetic 98 % 100 % 100 % 100 % 93 % 95 %
Geometric 98 % 100 % 100 % 100 % 97 % 96 %
1: therapeutic efficacy of the combination against day-2 infestation.
2: prophylactic efficacy against weekly tick re-infestation.
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products and for which percentages of efficacy are avail-
able in the literature [14-18]. As regards the percentages
of efficacy reported in the literature for fipronil-only and
permethrin-only mono-products, the comparison of the
results is in favor of the combination. Indeed, in a study
comparing two topical formulations of fipronil registered
within the European community at the same doses as the
combination, the therapeutic efficacies of fipronil against
I. ricinus varied between 93.8% and 98.8% whereas the
prophylactic efficacies varied between 77.2% and 100.0%
during the five weeks protection period [17].
In the same way, Endris et al. reported permethrin
percentages of efficacy against I. ricinus ranging from
74.1 to 99.1% in a first study and from 90.3 to 99.5% in a
second study [19,20]. In addition, the results published
by Epe et al. for a spot-on combination of Imidacloprid
10% (w/v)/Permethrin 50% (w/v) - with respectively
mainly insecticidal properties for imidacloprid and in-
secticidal and acaricidal properties for permethrin- are
also in favor of the combination of two molecules with
both acaricidal properties (fipronil/permethrin and fipro-
nil/amitraz). In particular, the therapeutic efficacies of
these fixed combination were better compared toTable 5 Published percentages of efficacy results of fipronil o
(geometric means) [17-21]
Active ingredient(s) Days after treatment
Day 2 Day 9
Fipronil + permethrin(a) 98% 100%
Fipronil(b) 98.8% 100.0%
Fipronil(c) 93.8% 100.0%
Imidacloprid + permethrin(d) 67.0% 100.0%
Fipronil + amitraz(e) 97.9% 100%




(b): Frontline ® Spot-on Dog Merial [17].
(c): Effipro® Spot-on Virbac SA [17].
(d): Imidacloprid 10% (w/v) / Permethrin 50% (w/v) Spot-on [18].
(e): CertifectTM Merial Limited [21].
(f): Defend® Exspot® Treatment for dogs, Schering-Plough Animal Health Corp., 65%
(g): Defend® Exspot® Treatment for dogs, Schering-Plough Animal Health Corp., 65%reported therapeutic efficacy of the imidacloprid/per-
methrin combination (respectively 67% for the imidaclo-
prid and permethrin combination versus 98% for the
fipronil and permethrin combination as shown above and
97.9% for the fipronil and amitraz combination [18,21]).
The results published in the literature for fipronil and
permethrin-based products are summarized in Table 5.
The combination of fipronil and permethrin shows
globally numerically better therapeutic and prophylactic
efficacies against I. ricinus than fipronil and permethrin
mono- products. Consequently, combining fipronil and
permethrin in the same formulation did not exhibit any
antagonist effect; on the contrary, an improvement of
the acaricidal efficacy against I. ricinus was shown.
Repellent (anti-feeding) effect
In addition to its acaricidal properties, permethrin has
been shown to have a strong repellent effect for a variety
of arthropods including I. ricinus when applied to cloth
or directly on the dog. Permethrin has been shown to be
a contact repellent meaning that ectoparasites must
come in contact with the molecule to be affected [22].
Miller et al. have shown that less than two hours expos-
ure was sufficient to cause the ticks (I. ricinus) to move
away from a permethrin-coated surface. Treatment of
dogs with a 65% permethrin spot-on reduced tick num-
bers on dogs by 99.1% at 2 days, 99.0% at one week, 95.9%
at two weeks, 88.5% at three weeks, 87.1% at four weeks
post-treatment. In contrast, treatment of dogs with 9.7%
fipronil did not reduce significantly tick numbers, after
two hours exposure, as compared to the control group.
These data indicate that I. ricinus are highly susceptible to
permethrin. Permethrin provides a high level of protection
and prevention in dogs by killing rapidly and repellingr permethrin based products against Ixodes ricinus
Day 16 Day 23 Day 30 Day 37
100% 100% 97% 96%
100.0% 100.0% 86.3% 77.2%
100.0% 98.9% 97.9% 94.1%
100.0% 99.5% 98.7% 91.6%
100% 98.1% 97.7% 96.3%
Day 14 Day 21 Day 28 Day 35
95.9% 88.5% 87.1% 74.1%
99.5% 90.7% 90.3% 91.3%
permethrin[19].
permethrin [20].
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when using highly concentrated formulations.
The design followed in this study evaluated only the
acaricidal effect of the combination as 48 h time interval
was allowed between the tick infestation and the evalu-
ation of the efficacy. However the combination of per-
methrin and fipronil should show at least the same
repellent properties as permethrin alone.
Consequently, with the use of a fipronil and permethrin
combination, the protection against I. ricinus will combine
an excellent killing effect together with repellent properties.
The primary concern about ticks is their ability to trans-
mit vector-borne diseases. B. burgdorferi, the causal agent
of Lyme disease is predominately transmitted by Ixodes
ticks. The maximum transmission of the spirochete occurs
between 48 and 72 h after the nymph attachment
[17,23-25]. Similarly, the transmission of the human gran-
ulocytic ehrlichiosis agent, A. phagocytophilum was esti-
mated to require at least 30 h in an experimental mice
model infested with Ixodes nymphs [26]. Therefore, an ex-
cellent killing effect of I. ricinus together with a repellent
effect are prudent measures to be included in an adequate
protection strategy against Lyme disease transmission
agents and potentially other vector-borne diseases.
Resistance
Another speculative advantage of combining fipronil and
permethrin may be to slow the development of resist-
ance against both actives. If some parasites are less sus-
ceptible to one of the active ingredients, the second one
will be active on them, and therefore prevent the emer-
gence of these resistant-strains. This is particularly true
when the mechanisms of resistance are independent and
initially rare [27-29].
So far, no evidence of established resistance to fipronil
and permethrin in dogs’ ticks and fleas has been reported
in Europe [30].
If it can be proven by further studies that the adminis-
tration of the combination could actually delay the devel-
opment of resistance against fipronil and/or permethrin in
Europe, this would be a huge step forward.
Conclusions
The artificial infestation model with I. ricinus used for
this study provided a challenge to assess the Effitix® acar-
icidal effect compared to natural conditions. This study
has shown that Effitix® is a safe and an effective combin-
ation to treat and protect dogs from I. ricinus up to
37 days after administration. The excellent immediate ef-
ficacy of 98% evaluated 48 hours post Effitix treatment
provides a rapid control of tick infestation. This combin-
ation can be used as a part of the strategy to control tick
infestations, in particular when there is a risk of trans-
mission of vector-borne diseases by ticks.Competing interests
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